CDK9-IN-19 is a selective and potent CDK9 inhibitor (IC50: 2.0 nM). CDK9-IN-19 exhibits good anti-proliferative activity in cancer cells, moderate pharmacokinetic properties and low hERG inhibition. CDK9-IN-19 significantly inhibited tumor growth in the MV4-11 xenograft mouse model. CDK9-IN-19 can be used in studies of acute myeloid leukemia (AML).
Molecular Weight:
508.47
CAS Number:
[2479306-60-8]
Formula:
C26H22F2N4O5
Target:
CDK|||Others
T63490
* VAT and and shipping costs not included. Errors and price changes excepted